Evidence map›Paper›PMID 35492106›Full record

ReviewRSC advances2020

Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy.

Seyyed Mojtaba Mousavi, Foo Wah Low, Seyyed Alireza Hashemi, Nurul Asma Samsudin, Mohammad Shakeri, Yulisa Yusoff, Mansoor Rahsepar, Chin Wei Lai, Aziz Babapoor, Sadaf Soroshnia and 3 more

Abstract readReview
In one paragraph

Review in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Seyyed Mojtaba MousaviDepartment of Chemical Engineering, National Taiwan University of Science and Technology Taiwan.
Foo Wah LowInstitute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia lowfw@uniten.edu.my.
Seyyed Alireza HashemiDepartment of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore Singapore.
Nurul Asma SamsudinInstitute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia lowfw@uniten.edu.my.
Mohammad ShakeriInstitute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia lowfw@uniten.edu.my.
Yulisa YusoffInstitute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia lowfw@uniten.edu.my.
Mansoor RahseparDepartment of Materials Science and Engineering, School of Engineering, Shiraz University Shiraz Iran.
Chin Wei LaiNanotechnology & Catalysis Research Centre, Level 3, Block A, Institute for Advanced Studies Building, University of Malaya 50603 Kuala Lumpur Malaysia cwlai@um.edu.my.ORCID https://orcid.org/0000-0002-7549-5015
Aziz BabapoorDepartment of Chemical Engineering, University of Mohaghegh Ardabili (UMA) Ardabil Iran.
Sadaf SoroshniaDepartment of Chemical Engineering, University of Mohaghegh Ardabili (UMA) Ardabil Iran.
Su Mei GohDepartment of Chemical Engineering, University of Mohaghegh Ardabili (UMA) Ardabil Iran.
Sieh Kiong TiongCollege of Engineering, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia.
Nowshad AminInstitute of Sustainable Energy, Universiti Tenaga Nasional (@The Energy University) Jalan IKRAM-UNITEN 43000 Kajang Selangor Malaysia lowfw@uniten.edu.my.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, chemotherapy is one of the crucial and common therapies in the world. So far, it has been revealed to be highly promising, yet patients suffer from the consequences of severe negative medical dosages. In order to overcome these issues, the enhancement of photothermal chemotherapy with reduced graphene oxide (rGO) as a photothermal agent (PTA) is widely utilised in current medical technologies. This is due to its high near-infrared region (NIR) response,

Identifiers

PMID35492106
PMCPMC9051426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.